YOUR
Search

    14.03.2016

    Altana advises ONXEO in the acquisition of DNA Therapeutics


    Altana advises ONXEO, a company listed on Compartment B of Euronext Paris and on the Copenhagen NASDAQ, in the execution of a binding agreement to acquire DNA Therapeutics.

     

    DNA Therapeutics is a biopharmaceutical company, with first-in-class therapeutic molecule in the cancer treatment. This new acquisition allows ONXEO to expand its pipeline and opens new opportunities in new orphan oncology indications.

     

    The acquisition of DNA Therapeutics demonstrates once again ONXEO’s commitment to be a leader in the development of new drugs in the orphan oncology treatments and ranks the Company at the forefront of scientific research with the potential to generate significant value for its stakeholders.

     

    According to the terms of the agreement; ONXEO will acquire DNA Therapeutics for an upfront payment of € 1.7 million payable at closing in ONXEO common shares. An additional payment will be made in an amount of € 1 million payable in ONXEO shares or in cash at ONXEO’s discretion, upon successful initiation of a Phase II trial in one of the selected indications. Finally, royalty payments on future commercial sales will be payable up to € 25 million per indication.

     

    ALTANA had previously advised ONXEO (formerly BIOALLIANCE PHARMA) in its cross-border merger with the Danish company TOPOTARGET in 2014. This merger was the first-ever cross border merger of a French listed company with a listed company of a different nationality under the 2005 merger Directive.

     

    - Acquirer: ONXEO

     

    - Legal advisors: ALTANA (Jean-Nicolas Soret / Fabien Pouchot)

     

    - Tax advisors: ARSENE TAXAND (Olivier Vergniolle / Marion Dervieux)

     

    - Financial advisors: ERNST & YOUNG (Jérôme Vailland / Mehdi Houkari)

     

    - Seller: DNA Therapeutics Shareholders

     

    - Legal advisors: HBC Avocats (Erwan Cossé / Laurent Comperot)

    Appointments at ADVANT Altana
    Amélie d'Heilly joins the Employment Law department as partner Géraldine Malfait co-opted as partner in Corporate M&A team Alexandre Véran appointed Counsel in the Employment Law team   Amélie d'Heilly…
    Read more
    ADVANT Altana advised Tutélaire in its expansion into retirement savings
    Tutélaire has just received approval from the Autorité de Contrôle Prudentiel et de Résolution (ACPR) for the transfer of the CAREL and Mutex SA supplementary pension portfolios for local elected represent…
    Read more
    ADVANT Altana advises Anett on the acquisition of Kalhyge Group
    Paris, 13 November 2024 - ADVANT Altana advised the family-owned Anett Group on its merger with Kalhyge.
    Read more
    ADVANT Altana advised Amplitude Laser Group on the sale of Continuum to Lumibird
    Paris, 12 November 2024 - ADVANT Altana advised Amplitude Laser Group on the sale of its Continuum nanosecond lasers business and its related service activity.
    Read more
    ADVANT Altana advises Artelia on the acquisition of ADP Ingénierie (ADPI)
    Paris, October 30, 2024 - ADVANT Altana advised Artelia, an international multidisciplinary consulting, engineering and project management group, on the acquisition of 100% of the shares in ADP Ingénierie …
    Read more
    ADVANT Altana advises Loca Service Group on the opening of its capital to a pool of investors
    ADVANT Altana advised the industrial group Loca Service on the opening up of its capital to a pool of minority investors, led by the investment fund NCI Capital and including BNP Paribas Développement, BP …
    Read more
    ADVANT Altana advises Cegid on the acquisition of KMB Labs
    ADVANT Altana has advised Cegid, the European leader in cloud management solutions, on the acquisition of KMB Labs, a French HR tech start-up. This acquisition will enable Cegid to complete its portfolio …
    Read more
    ADVANT Altana advised the founders of the Huguenin Group on the acquisition of a majority stake by FrenchFood Capital
    ADVANT Altana has advised the founders of the Huguenin Group, a key player in the production of meat products for top chefs, on the acquisition of a majority stake in the group’s capital by FrenchFood Capi…
    Read more
    ADVANT Altana advises AIRESS on its sale to the Trajan investment fund
    ADVANT Altana has advised the family group controlling AIRESS on its sale in the form of a buy-in management buy-out (BIMBO) to the Trajan investment fund, specialised in the transfer of capital and the ma…
    Read more